Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism.

about

Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism.

Item

http://www.wikidata.org/entity/Q52374806

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Major Histocompatibility Compl ...... he Classical HLA Polymorphism.

@en

Major Histocompatibility Compl ...... he Classical HLA Polymorphism.

@nl

type

Item

label

Major Histocompatibility Compl ...... he Classical HLA Polymorphism.

@en

Major Histocompatibility Compl ...... he Classical HLA Polymorphism.

@nl

prefLabel

Major Histocompatibility Compl ...... he Classical HLA Polymorphism.

@en

Major Histocompatibility Compl ...... he Classical HLA Polymorphism.

@nl

P1476

Major Histocompatibility Compl ...... he Classical HLA Polymorphism.

@en

P2093

Alice Bertaina

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation

NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation

Specificity pockets for the side chains of peptide antigens in HLA-Aw68

Nomenclature for factors of the HLA system, 2004

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation

P31

scholarly article

review article

P356

10.3390/IJMS19020621

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marco Andreani

P577

2018-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29470425

http://www.w3.org/2001/XMLSchema#string

P921

genetic variation

P932

5855843

http://www.w3.org/2001/XMLSchema#string